icon
موقع حكومي رسمي تابع لحكومة المملكة العربية السعودية
icon الخميس 10 محرم 1448هـ
نسخة تجريبية
icon
روابط المواقع الالكترونية الرسمية السعودية تنتهي بـ gov.sa

جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa

icon
المواقع الالكترونية الحكومية تستخدم بروتوكول HTTPS للتشفير والأمان.

جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa

icon
مسجل لدى هيئة الحكومة الرقمية برقم :
20250831619
اقتراحات

قائمة الدراسات السريرية المسجلة على الادوية

عرض 371 - 380 من 485
عنوان الدراسة داعم الدراسة حالة الدراسة دواء الدراسة مرحلة الدراسة رقم بروتوكول الدراسة موقع الدراسة
Saudi rEgistry of Cardiovascular Risk factor managEmenT in HemoDialysis patients Sanofi Ongoing N/A 4 2 King Abdulaziz University Hospital (Jeddah), King Fahad Hospital (Jeddah), King Khalid General Hospital (Hail), King Abdulaziz University Hospital (Jeddah), Al-Noor Specialist Hospital (Makkah), Dr. Soliman Fakeeh Hospital (Jeddah), King Salman Kidney Diseases Center (Riyadh)
A multicenter, observational, phase IV study of the use of Pregabalin (Nervax®) on adult patients for the management of Neuropathic pain in Saudi Arabia Tabuk Pharmaceuticals Ongoing NERVAX 4 N-001 King Fahad Medical City (Riyadh)
A multicenter, observational, prospective study of the use of Diclofenac Sodium 75 mg Dual Release Capsules (Divido®) on adult patients with persistent or chronic pain and inflammation in Saudi Arabia Tabuk Pharmaceuticals Ongoing Divido 4 D-001 King Fahad Medical City (Riyadh)
Multinational, Prospective, Observational Study to Assess the Unmet Medical Needs associated with Basal Insulin Use in Patients with Type 2 Diabetes Newly or Recently Initiated with Basal Insulin Treatment Sanofi Ongoing N/A 4 OBS13780 King Khalid University Hospital (Riyadh)
Evaluation of Asthma Management in Middle EAst North Africa Adult population ( ESMAA Study ) AstraZeneca Ongoing N/A 4 RME-XXX-20 Soliman Fakeeh Hospital (Jeddah), King Abdulaziz Hospital and Oncology Center (Jeddah), Armed Forces Hospital (dhahran), King Khalid University Hospital (Riyadh), King Fahad Medical City (Riyadh), Armed Forces Hospital (Taif), King Fahad Specialist Hospital (Dammam), International Medical Center (Jeddah), King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah)
Verifying Insulin Strategy and Initial Health Outcome Analysi Eli Lilly Ongoing N/A 4 F3Z-MC-B01 International Medical Center (Jeddah), King Fahd University Hospital (al khobar), King Fahad Medical (City), Armed Forces Hospital (Taif)
The Effect of Vitamin D3 on Biomarkers of Glycaemia and Oxidative Stress in Saudi Men with Poorly-Controlled Type 2 Diabetes Mellitus King Fahad Medical City Ongoing Vitamin D Capsules 4 H-01-R-012 King Fahad Medical City (Riyadh)
(LUMINOUS)Study to observe the effectiveness andsafety of ranibizumab through individualized patienttreatment and associated Novartis Ongoing Ranibizumab 10mg/ml (Lucentis) 4 FB002A2406 King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah) , Prince Sultan Military Medical City (Riyadh)
Use Of High Dose Colistin in Multi Drug Resistant Gram Negative Infections in Critically Ill Adult Patients. Randomized Controlled Clinical Trial King Saud Medical City Ongoing Colistin 4 CCD-AFM-00 King Saud Medical City (Riyadh)
Dyslipidemia International Study II: Lipid target achievement in high risk patients with Acute Coronary Syndrome (DYSIS II) MSD Ongoing N/A 4 0653A 427 Riyadh Care Hospital  (Riyadh), Dr. Soliman Fakeeh Hospital (Jeddah), King Faisal Specialist Hospital and Research Center (Riyadh)